134 related articles for article (PubMed ID: 6149425)
1. Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.
Jüngst D
Lancet; 1984 Nov; 2(8410):1043. PubMed ID: 6149425
[No Abstract] [Full Text] [Related]
2. Treatment of malignant hypercalcaemia with clodronate.
Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
[TBL] [Abstract][Full Text] [Related]
3. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
[TBL] [Abstract][Full Text] [Related]
4. Immobilisation hypercalcaemia in adults and treatment with clodronate.
Yates AJ; Jones TH; Mundy KI; Hague RV; Brown CB; Guilland-Cumming D; Kanis JA
Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1111-2. PubMed ID: 6237713
[No Abstract] [Full Text] [Related]
5. [Monotherapy with clodronate for tumor-induced hypercalcemia].
Harjung H; Fritze D
Dtsch Med Wochenschr; 1990 Jan; 115(2):48-52. PubMed ID: 2136827
[TBL] [Abstract][Full Text] [Related]
6. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
Lind L; Wengle B; Ljunghall S
Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative normalization of hypercalcemia, caused by parathyroid cancer, by intravenous administration of dichloromethylene diphosphonate].
Conte N; Di Virgilio R; Roiter I
Minerva Endocrinol; 1984; 9(1):47-8. PubMed ID: 6239086
[No Abstract] [Full Text] [Related]
8. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
[TBL] [Abstract][Full Text] [Related]
9. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
[TBL] [Abstract][Full Text] [Related]
10. Use of diphosphonates in hypercalcaemia due to malignancy.
Kanis JA; McCloskey EV; Paterson AH
Lancet; 1990 Jan; 335(8682):170-1. PubMed ID: 1967461
[No Abstract] [Full Text] [Related]
11. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
[TBL] [Abstract][Full Text] [Related]
12. Use of bisphosphonates in hypercalcaemia due to malignancy.
Ralston SH; Gallacher SJ; Patel U; Fraser WD; Dryburgh FJ; Boyle IT
Lancet; 1990 Mar; 335(8691):737. PubMed ID: 1969100
[No Abstract] [Full Text] [Related]
13. Comparative effects of calcitonin and clodronate in hypercalcaemia.
Ljunghall S; Rastad J; Akerström G
Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
[TBL] [Abstract][Full Text] [Related]
14. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
[TBL] [Abstract][Full Text] [Related]
15. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
[TBL] [Abstract][Full Text] [Related]
16. The bisphosphonate dilemma.
Koyano H; Schimizu T; Shishiba Y
J Nucl Med; 1995 Apr; 36(4):705-6. PubMed ID: 7699469
[No Abstract] [Full Text] [Related]
17. [Hypercalcemia during immobilization and prolonged anuria treated with disodium clodronate].
Evald T; Jensen GV; Garde K
Ugeskr Laeger; 1992 Jul; 154(31):2158-9. PubMed ID: 1387269
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
[TBL] [Abstract][Full Text] [Related]
19. [Diphosphonates in the treatment of hypercalcemia].
Delmas PD; Meunier PJ
Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
[TBL] [Abstract][Full Text] [Related]
20. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
